Abstract
Momordica charantia L. is a medicinal plant commonly used in the management of diabetes mellitus. We investigated the blood glucose lowering effect of the methanolic fruit extract of the Ugandan variety of M. charantia L. in alloxan-induced diabetic albino rats. 500g of M. charantia powder were macerated in methanol and the extract administered to two groups of alloxan-induced diabetic rats. The first group received 125mg/kg, the second 375mg/kg and a third group 7mg/kg of metformin. A fourth group received 1ml normal saline. Fasting blood glucose (FBG) levels were measured at 0.5,1,2,3,5,8 and 12 hours and compared using one-way ANOVA. There was an initial rise in FBG for 1 hour after administration of extracts followed by steep reductions. Significant reduction in FBG occurred at 2 hours for 125mg/kg of extract (-3.2%, 313±25.9 to 303±25.0mg/dL, p = 0.049), 375mg/kg of extract (-3.9%, 356±19.7 to 342±20.3mg/dL, p = 0.001), and metformin (-2.6%, 344±21.7 to 335±21.1mg/dL, p = 0.003) when compared to normal saline. The maximum percentage reduction in FBG by both extracts occurred between 3 and 12 hours post dose. The methanolic fruit extract of M. charantia exhibits dose dependent hypoglycaemic activity in vivo.
Highlights
Diabetes Mellitus (DM) is a leading cause of illness and death in developed countries and is epidemic in many developing and newly industrialized countries
This study aimed at investigating the effects of the Ugandan variety of M. charantia L. methanolic fruit extract on blood glucose levels in alloxaninduced diabetic rats
There was an initial increase in the Fasting blood glucose (FBG) when the extract was administered, which lasted the first 1 hour
Summary
Diabetes Mellitus (DM) is a leading cause of illness and death in developed countries and is epidemic in many developing and newly industrialized countries. The prevalence of diabetes in the world at all ages was estimated to be 2.8% in 2000, and it is expected to approximate 4.4% in the year 2030.The estimated global number of people of all ages and sex with diabetes in 2000 was 171 million This is projected to increase to 366 million by 2030, with about 4 million deaths every year attributed to its complications[1,2]. Significant reduction in FBG occurred at 2 hours for 125mg/kg of extract (-3.2%, 313±25.9 to 303±25.0mg/dL, p = 0.049), 375mg/ kg of extract (-3.9%, 356±19.7 to 342±20.3mg/dL, p = 0.001), and metformin (-2.6%, 344±21.7 to 335±21.1mg/dL, p = 0.003) when compared to normal saline.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
